Paper of the Month - March, 2011

0 rating

[1] Effect of aspirin and NSAIDs on risk and survival from colorectal cancer

Din FV, Theodoratou E, Farrington SM et al.
Aspirin is currently recommended to reduce the incidence of cardiovascular events in patients with risk factors for cardiovascular disease. However, it is well-known that the risks of aspirin (e.g. gastrointestinal bleeding) may outweigh its benefits. A recent review of randomized clinical trials showed that a daily aspirin reduces the mortality rates of several common cancers, including colorectal cancer (CRC), but there is not yet agreement on its recommended daily dosage or treatment duration in these settings (Lancet 2011;377:31–41).


This journal is supported by an educational grant from

READER POLL

Colorectal Cancer 3
Which imaging technique do you consider to be the most effective in the clinical staging of colorectal cancer?





Powered by NetPolls

SUBMIT AN ARTICLE